| Financial Year |
March 31 2023 |
| Monetary Funds |
142,596,525.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,917,298.48 |
| Accounts Receivable |
147,398,013.48 |
| Advances to Suppliers |
7,541,524.46 |
| Other Receivables |
621,297.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
112,409,466.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,939,727.41 |
| Total Current Assets |
416,423,853.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
411,322,954.65 |
| Under-construction Projects |
26,422,953.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,872,532.02 |
| R&D expenses |
3,692,975.87 |
| Goodwill |
50,774,526.05 |
| Long-Term Deferred and Prepaid Expenses |
1,207,415.38 |
| Deferred Income Tax Assets |
8,560,104.93 |
| Other Non-Current Assets |
8,842,590.96 |
| Sub-Total of Non-Current Assets |
525,696,053.05 |
| Total Assets |
942,119,906.39 |
| Short-Term Loans |
90,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
77,138,984.89 |
| Accounts Payable |
99,384,517.91 |
| Accounts Received In Advance |
180,900.09 |
| Employee Compensation Payable |
2,453,327.88 |
| Taxes Payable |
3,726,413.90 |
| Interest Payable |
-- |
| Dividend Payable |
905,550.24 |
| Other payables |
3,520,223.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
22,233.45 |
| Sub-Total of Current Liabilities |
276,740,706.56 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,806,942.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,865,679.90 |
| Total Liabilities |
312,606,386.46 |
| Paid-In Capital(Or Share Stock) |
153,340,000.00 |
| Capital Surplus |
195,868,214.42 |
| Surplus Reserve |
26,400,961.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
253,904,343.84 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
629,513,519.93 |
| Owner's Equity（Stockholder's Equity） |
629,513,519.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
942,119,906.39 |
